Inactive Instrument

MEDH ACQU

Equities

MTAC

US58507N1054

Medtech Acquisition Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021

August 16, 2021 at 05:02 pm EDT

MedTech Acquisition Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 783,925. Net income was USD 378,866. For the half year, operating loss was USD 1.091 million. Net income was USD 6,832.

Latest news about MEDH ACQU

MedTech Acquisition, TriSalus Life Sciences Complete Merger	23-08-10	MT
MedTech Acquisition Corporation(NasdaqCM:MTAC) dropped from NASDAQ Composite Index	23-08-10	CI
Trisalus Life Sciences Inc. completed the acquisition of MedTech Acquisition Corporation from Medtech Acquisition Sponsor LLC, Magnetar Financial LLC and others.	23-08-09	CI
Top Premarket Gainers	23-08-08	MT
MedTech Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
MedTech Acquisition Corporation announced that it has received $0.137375 million in funding	23-06-14	CI
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases At the Asco 2023 Annual Meeting	23-06-12	CI
MedTech Acquisition Corporation announced that it expects to receive $17.85502 million in funding	23-06-06	CI
MedTech Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
MedTech Acquisition Corporation Auditor Raises 'Going Concern' Doubt	23-03-21	CI
Magnetar Capital Engages in Discussions with MedTech Acquisition Corporation	23-02-09	CI
MedTech Acquisition Corporation announced that it has received $1.468821 million in funding from Medtech Acquisition Sponsor LLC	22-12-15	CI
TriSalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncologyâ„¢ (PERIOâ„¢) Clinical Trial Progress and Pre-clinical Research Developments	22-12-15	CI
TriSalus Life Sciences to Merge With MedTech Acquisition to Go Public	22-11-14	MT
Trisalus Life Sciences Inc. entered into a definitive merger agreement to acquire MedTech Acquisition Corporation from Medtech Acquisition Sponsor LLC, Magnetar Financial LLC and others for $220 million in a reverse merger transaction.	22-11-13	CI
MedTech Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
MedTech Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-10	CI
MedTech Acquisition Corporation announced that it has received $1.5 million in funding from Medtech Acquisition Sponsor LLC	22-05-23	CI
MedTech Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11	CI
MedTech Acquisition, Memic Innovative Surgery Agree to Terminate Merger Agreement	22-03-10	MT
Memic Innovative Surgery Ltd. cancelled the acquisition of MedTech Acquisition Corporation from a group of sellers in a reverse merger transaction.	22-03-08	CI
MedTech Acquisition Corporation Announces Board Changes	22-03-08	CI
MedTech Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-03	CI
MedTech Acquisition Corporation Auditor Raises 'Going Concern' Doubt	22-03-02	CI
MedTech Acquisition Corporation Announces Management Changes	22-02-23	CI

Chart MEDH ACQU

Duration

Period

More charts

Company Profile

MedTech Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on businesses primarily operating in the healthcare sector in the United States. The Company has not commenced any business operations and has not generated any revenue.

Sector

More about the company